Streetbeat News

Regulatory

EWC

SPY

The Bank of Canada has decided to raise interest rates immediately, citing evidence that supports the move.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2023 | 5:36 pm

LLY

The U.S. FDA has approved Jardiance (empagliflozin) for the treatment of type 2 diabetes in children aged 10 and older. Jardiance, developed by Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY), is the first and only SGLT2 inhibitor approved for this patient population.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 5:16 pm

SPY

Federal Reserve Chairman Jerome Powell stated that the reverse repo program is not impacting the economy and has seen volumes decline since the Treasury began increasing issuance. The extent of the reverse repo program's shrinkage remains uncertain.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 5:06 pm

BTCUSD

ETHUSD

SPY

Federal Reserve Chairman Jerome Powell stated that cryptocurrencies seem to have staying power as an asset class, acknowledging their growing importance in the financial landscape.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 5:01 pm

SPY

Federal Reserve Chairman Jerome Powell warns of commercial real estate losses in the office and mall sectors, which may lead to a difficult time for banks with a high concentration of those loans.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 4:56 pm

SPY

Fed's Goolsbee says that they probably won't gain enough information in the next 6 weeks to make a definitive decision, but they will learn more. Progress or lack thereof will provide an answer.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 4:49 pm

SPY

Fed's Goolsbee admits that the Federal Reserve failed to prevent inflation and that their forecasting was mistaken. He states that inflation is pervasive around the world and the Fed's current framework is 'wait and see'.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 4:48 pm

SPY

Fed's Goolsbee expects to see clearer indications on the persistence of inflation in the coming months, with goods inflation potentially decreasing and housing inflation falling by the fall.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 4:47 pm

ALDX

Aldeyra Therapeutics received a Complete Response Letter from the FDA for the NDA of ADX-2191 due to lack of substantial evidence of effectiveness. The company plans to discuss ADX-2191 for PVRL with the FDA and explore an Expanded Access Program protocol. ALDX shares are down 24.80%.

Portfolio Pulse from Vandana Singh

June 21, 2023 | 4:43 pm

SPY

Fed's Goolsbee stated that the decision last week was a close call for him, indicating a divided opinion within the Federal Reserve.

Portfolio Pulse from Happy Mohamed

June 21, 2023 | 4:42 pm